Capitalization 245B P/E ratio 2024 *
28.1x
P/E ratio 2025 * 23.4x
Enterprise value 232B EV / Sales 2024 *
5.14x
EV / Sales 2025 * 4.67x
Free-Float
96.64%
Yield 2024 *
1.95%
Yield 2025 * 2.06%
More valuation ratios * Estimated data
Dynamic Chart

Last Transcript: AstraZeneca PLC

1 day+0.20%
1 week+0.94%
Current month-1.15%
1 month-2.07%
3 months+8.40%
6 months+16.86%
Current year+15.23%
More quotes
1 week
12 006.00
Extreme 12006
12 394.00
1 month
11 872.00
Extreme 11872
12 704.00
Current year
9 461.00
Extreme 9461
12 704.00
1 year
9 461.00
Extreme 9461
12 704.00
3 years
8 029.00
Extreme 8029
12 704.00
5 years
5 871.00
Extreme 5871
12 704.00
10 years
3 680.00
Extreme 3680
12 704.00
More quotes
Insider TitleAgeSince
Chief Executive Officer 64 12-09-30
Chief Operating Officer 53 15-05-31
Compliance Officer - 94-12-31
Insider TitleAgeSince
Director/Board Member 68 99-03-31
Chief Executive Officer 64 12-09-30
Director/Board Member 63 17-04-26
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.20%+0.94%+13.41%+44.03% 244B
-2.10%-8.68%+86.11%+252.19% 791B
-2.16%-6.97%+62.71%+216.13% 595B
+2.58%+3.49%-8.17%-9.03% 367B
+1.24%+0.38%+14.07%+62.39% 315B
+1.77%+4.14%+22.59%+49.09% 306B
+0.07%+5.64%-0.40%-21.25% 247B
+0.08%-2.67%+5.47%+13.82% 218B
+0.71%+0.74%+42.92%+35.48% 179B
+1.63%+1.63%-19.84%-28.07% 167B
Average -0.13%-0.24%+21.89%+61.48% 342.87B
Weighted average by Cap. -0.63%-1.02%+35.72%+107.78%
See all sector performances
Ratios2024 *2025 *
Net sales 51.65B 55.5B
Net income 8.73B 10.45B
Net Debt 21B 14.53B
More financial data * Estimated data
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Employees
89,900
More about the company
Date Price Change Volume
24-07-24 12,214.00 p +0.20% 1,698,778
24-07-23 12,190.00 p -0.57% 2,173,586
24-07-22 12,260.00 p +1.27% 1,926,469
24-07-19 12,106.00 p -0.16% 985,409
24-07-18 12,126.00 p -0.96% 891,089

Delayed Quote London S.E., July 24, 2024 at 11:35 am EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
157.83USD
Average target price
177.79USD
Spread / Average Target
+12.65%
Consensus